Breaking News Instant updates and real-time market news.

AKBA

Akebia

$15.25

0.2 (1.33%)

, FGEN

FibroGen

$43.35

0.95 (2.24%)

16:30
12/18/17
12/18
16:30
12/18/17
16:30

Akebia initiated with an Overweight at Piper Jaffray

Piper Jaffray analyst Christopher Raymond initiated Akebia (AKBA) with an Overweight rating and a price target of $26. The analyst cites the company's "combination of sound biology, clean safety, meaningful unmet medical need and an attractive relative valuation". While the near term prospects for Akebia revolve around first-to- market player Fibrogen (FGEN) in the HIF space, the analyst contends, Akebia can generate its own share of anemia market once its lead compound vadadustat is approved.

AKBA

Akebia

$15.25

0.2 (1.33%)

FGEN

FibroGen

$43.35

0.95 (2.24%)

AKBA Akebia
$15.25

0.2 (1.33%)

12/07/17
12/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Sogou (SOGO) initiated with an Overweight at JPMorgan. 2. Amag Pharmaceuticals (AMAG) initiated with a Neutral at B. Riley FBR. 3. Akebia (AKBA) initiated with a Buy at BTIG. 4. Synnex (SNX) initiated with a Buy at SunTrust. 5. Cancer Genetics (CGIX) initiated with a Buy at Maxim. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
12/07/17
BTIG
12/07/17
INITIATION
Target $30
BTIG
Buy
Akebia initiated with a Buy at BTIG
BTIG analyst Robert Hazlett initiated Akebia with a Buy rating and a price target of $30. Hazlett says the company's development of Vadadustat - an HIF-PH inhibitor for anemia secondary to chronic kidney disease - has the potential to attain "hemoglobin control with material advantages compared to current standard-of-care injectable erythropoiesis stimulating agents". With its development partnerships in Japan and EU, the treatment is in a Phase 3 program expected for readouts in the first half of 2019.
11/15/17
HCWC
11/15/17
NO CHANGE
Target $24
HCWC
Buy
Akebia recent selloff not based on fundamentals, says H.C. Wainwright
H.C. Wainwright analyst Ed Arce notes that since the close on November 8, shares of FibroGen (FGEN) are down 17% while Akebia Therapeutics (AKBA) is down 21.3%. He attributes some of the weakness to FibroGen's Q3 earnings call, in which concerns arose that cardiovascular events in the large Phase 3 roxadustat cardiovascular outcomes trials are accruing too slowly. The analyst believes this has no fundamental bearing on Akebia or vadadustat, however. He keeps a Buy rating on the shares with a $24 price target.
10/04/17
MZHO
10/04/17
INITIATION
MZHO
Buy
Akebia initiated with a Buy at Mizuho
FGEN FibroGen
$43.35

0.95 (2.24%)

10/04/17
MZHO
10/04/17
INITIATION
MZHO
Neutral
FibroGen initiated with a Neutral at Mizuho
08/14/17
JEFF
08/14/17
NO CHANGE
JEFF
Buy
Expert IPF call positive for FibroGen, says Jefferies
Jefferies analyst Michael Yee says his call with two idiopathic pulmonary fibrosis experts was net positive for FibroGen (FGEN). Based on the available data, the experts estimated a 30%-40%-plus probability of success in Phase 3 for the company. The experts were "more conservative in the interpretation" of the data reported by Galapagos NV (GLPG), Yee tells investors in a research note. He reiterates a Buy rating on FibroGen given the "underappreciated value" for FG-3019 in IPF.
08/08/17
LEER
08/08/17
NO CHANGE
Target $82
LEER
Outperform
FibroGen price target raised to $82 from $52 at Leerink
Leerink analyst Geoffrey Porges raised his price target for FibroGen to $82 from $52 after the company reported Q2 results and disclosed positive top-line results for the first phase of the ongoing phase II trial of pamrevlumab in idiopathic pulmonary fibrosis. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

$NSD

NASDAQ Market Internals

10:17
01/18/18
01/18
10:17
01/18/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

10:16
01/18/18
01/18
10:16
01/18/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

10:16
01/18/18
01/18
10:16
01/18/18
10:16
Hot Stocks
Amazon names 20 finalists in race for second headquarters »

Shares of Amazon.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 18

    Mar

10:15
01/18/18
01/18
10:15
01/18/18
10:15
General news
Breaking General news story  »

Week of 1/12 EIA Natural…

TLT

iShares 20+ Year Treasury Bond Fund

$124.87

-0.17 (-0.14%)

10:10
01/18/18
01/18
10:10
01/18/18
10:10
Options
Defensive option play in iShares Longer-term Bond Fund »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:10
01/18/18
01/18
10:10
01/18/18
10:10
General news
Treasury Option Action: heavy call positioning »

Treasury Option Action:…

LGF.A

Lionsgate

$33.69

1.41 (4.37%)

, CBS

CBS

$59.73

0.83 (1.41%)

10:05
01/18/18
01/18
10:05
01/18/18
10:05
Hot Stocks
Lionsgate jumps after report on potential takeover interest »

Shares of Lionsgate…

LGF.A

Lionsgate

$33.69

1.41 (4.37%)

CBS

CBS

$59.73

0.83 (1.41%)

CBS.A

$59.79

0.75 (1.27%)

VIA

Viacom

$37.85

0.95 (2.57%)

VIAB

Viacom

$31.96

0.58 (1.85%)

AMZN

Amazon.com

$1,295.00

-9.86 (-0.76%)

VZ

Verizon

$52.68

0.955 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 23

    Jan

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 15

    Feb

  • 18

    Mar

ADM

Archer Daniels

$40.66

-0.25 (-0.61%)

10:04
01/18/18
01/18
10:04
01/18/18
10:04
Hot Stocks
Archer Daniels, Vland enter development agreement for feed enzyme technology »

Archer Daniels Midland…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

TIVO

TiVo

$14.50

0.1 (0.69%)

, GOOG

Alphabet

$1,131.98

10.22 (0.91%)

10:04
01/18/18
01/18
10:04
01/18/18
10:04
Recommendations
TiVo, Alphabet, Alphabet Class A analyst commentary  »

TiVo in 'great…

TIVO

TiVo

$14.50

0.1 (0.69%)

GOOG

Alphabet

$1,131.98

10.22 (0.91%)

GOOGL

Alphabet Class A

$1,139.10

8.4 (0.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

TEVA

Teva

$20.63

-0.85 (-3.96%)

, MYL

Mylan

$46.78

0.14 (0.30%)

10:03
01/18/18
01/18
10:03
01/18/18
10:03
Periodicals
Hospitals plan nonprofit generic drug company, NY Times says »

Some of the…

TEVA

Teva

$20.63

-0.85 (-3.96%)

MYL

Mylan

$46.78

0.14 (0.30%)

ENDP

Endo

$7.69

-0.32 (-4.00%)

NVS

Novartis

$86.53

-0.35 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 08

    Feb

  • 16

    Feb

  • 08

    Mar

  • 23

    Apr

  • 17

    May

CMTL

Comtech

$21.69

0.29 (1.36%)

10:01
01/18/18
01/18
10:01
01/18/18
10:01
Hot Stocks
Comtech receives $3.8M of orders from Middle East service provider »

Comtech announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MARA

Marathon Patent Group

$3.47

-0.12 (-3.34%)

10:00
01/18/18
01/18
10:00
01/18/18
10:00
Options
Marathon Patent calls active as shares rally »

Marathon Patent calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:00
01/18/18
01/18
10:00
01/18/18
10:00
General news
U.S. corporate bond update: a number of deals are slated »

U.S. corporate bond…

ONCS

OncoSec

$1.85

0.02 (1.09%)

09:58
01/18/18
01/18
09:58
01/18/18
09:58
Periodicals
OncoSec TBNC news 'interesting,' but 'hard to interpret,' says Feuerstein »

Adam Feuerstein of STAT…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AES

AES Corp.

$11.61

0.89 (8.30%)

, WYN

Wyndham

$123.46

6.33 (5.40%)

09:55
01/18/18
01/18
09:55
01/18/18
09:55
Options
Early notable gainers among liquid option names on January 18th »

Notable gainers among…

AES

AES Corp.

$11.61

0.89 (8.30%)

WYN

Wyndham

$123.46

6.33 (5.40%)

MTB

M&T Bank

$186.65

7.435 (4.15%)

PPG

PPG

$119.61

5.11 (4.46%)

RL

Ralph Lauren

$109.34

3.285 (3.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 18

    Jan

  • 01

    Feb

  • 14

    Feb

JLL

Jones Lang LaSalle

$152.68

-1.09 (-0.71%)

09:55
01/18/18
01/18
09:55
01/18/18
09:55
Conference/Events
House Transportation and Infrastructure Committee holds a hearing »

The Subcommittee on Water…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 07

    Feb

  • 07

    Feb

XLE

Energy Select Sector SPDR

$76.77

-0.34 (-0.44%)

, XLV

Health Care Select Sector SPDR

$88.01

-0.08 (-0.09%)

09:52
01/18/18
01/18
09:52
01/18/18
09:52
Technical Analysis
Technical Take: S&P 500 flat, sector breadth mixed »

The S&P 500 (SPX) was…

XLE

Energy Select Sector SPDR

$76.77

-0.34 (-0.44%)

XLV

Health Care Select Sector SPDR

$88.01

-0.08 (-0.09%)

XLK

Technology Select Sector SPDR

$67.70

0.15 (0.22%)

XLI

Industrial Select Sector SPDR

$80.04

0.145 (0.18%)

SPY

SPDR S&P 500 ETF Trust

$279.69

0.08 (0.03%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JXSB

Jacksonville Bancorp

09:50
01/18/18
01/18
09:50
01/18/18
09:50
Hot Stocks
Breaking Hot Stocks news story on Jacksonville Bancorp »

Jacksonville Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$41.68

-0.14 (-0.33%)

09:48
01/18/18
01/18
09:48
01/18/18
09:48
Recommendations
Comcast analyst commentary  »

Comcast price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jan

  • 24

    Jan

PTC

PTC

$66.70

1.41 (2.16%)

09:46
01/18/18
01/18
09:46
01/18/18
09:46
Recommendations
PTC analyst commentary  »

PTC price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VFC

VF Corp.

$78.40

0.26 (0.33%)

09:46
01/18/18
01/18
09:46
01/18/18
09:46
Hot Stocks
VF Corp. to open distribution center in Jonestown, PA, create 175 new jobs »

VF Corporation announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:45
01/18/18
01/18
09:45
01/18/18
09:45
General news
The U.S. housing starts report undershot estimates »

The U.S. housing starts…

KR

Kroger

09:43
01/18/18
01/18
09:43
01/18/18
09:43
Hot Stocks
Kroger investing $500M in human capital over next three years »

The Kroger Co announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEI

Heico

$96.89

19.378 (25.00%)

, HEI.A

HEICO

$79.40

15.88 (25.00%)

09:42
01/18/18
01/18
09:42
01/18/18
09:42
Hot Stocks
HEICO share prices adjusted for stock split »

HEICO Corporation…

HEI

Heico

$96.89

19.378 (25.00%)

HEI.A

HEICO

$79.40

15.88 (25.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:41
01/18/18
01/18
09:41
01/18/18
09:41
General news
Stocks pause after yesterday's rally, open little changed »

Stocks opened little…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.